Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer.
D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage*; D011929:Razoxane / Q000008:administration & dosage*; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000601:surgery
D010879:Piperazines; D011929:Razoxane